journal article·2024-04-26Open access

Cryopreservation and Rapid Recovery of Differentiated Intestinal Epithelial Barrier Cells at Complex Transwell Interfaces Is Enabled by Chemically Induced Ice Nucleation

Akalabya Bissoyi, Yanan Gao, Ruben M. F. Tomás, Nina L. H. Kinney, Thomas F. Whale, Qiongyu Guo, Matthew I. Gibson

Abstract

Cell-based models, such as organ-on-chips, can replace and inform in vivo (animal) studies for drug discovery, toxicology, and biomedical science, but most cannot be banked "ready to use" as they do not survive conventional cryopreservation with DMSO alone. Here, we demonstrate how macromolecular ice nucleators enable the successful cryopreservation of epithelial intestinal models supported upon the interface of transwells, allowing recovery of function in just 7 days post-thaw directly from the freezer, compared to 21 days from conventional suspension cryopreservation. Caco-2 cells and Caco-2/HT29-MTX cocultures are cryopreserved on transwell inserts, with chemically induced ice nucleation at warmer temperatures resulting in increased cell viability but crucially retaining the complex cellular adhesion on the transwell insert interfaces, which other cryoprotectants do not. Trans-epithelial electrical resistance measurements, confocal microscopy, histology, and whole-cell proteomics demonstrated the rapid recovery of differentiated cell function, including the formation of tight junctions. Lucifer yellow permeability assays confirmed that the barrier functions of the cells were intact. This work will help solve the long-standing problem of transwell tissue barrier model storage, facilitating access to advanced predictive cellular models. This is underpinned by precise control of the nucleation temperature, addressing a crucial biophysical mode of damage.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: 3D Printing in Biomedical Research · Planarian Biology and Electrostimulation · Microfluidic and Bio-sensing Technologies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry, University of Manchester, Oxford Road, Manchester M13 9PL, U.K.

Manchester Institute of Biotechnology, University of Manchester, 131 Princess Street, Manchester M1 7DN, U.K.

Department of Chemistry, University of Warwick, Coventry CV4 7AL, U.K.

Department of Biomedical Engineering, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China

Cryologyx Ltd, Venture Centre, University of Warwick Science Park, Coventry CV4 7EZ, U.K.

Royal Botanic Gardens Kew, Ardingly, West Sussex RH17 6TN, U.K.

School of Earth and Environment, University of Leeds, Leeds LS2 9JT, U.K.

Division of Biomedical Sciences, Warwick Medical School, University of Warwick, Coventry CV4 7AL, U.K.

Funding

Royal Society · Leverhulme Trust · Innovate UK · Natural Environment Research Council · Southern University of Science and Technology · National Natural Science Foundation of China · H2020 European Research Council · Biotechnology and Biological Sciences Research Council · University of Warwick · CryoLogyx Ltd. · Cytivia

References (50)

Show source-provided references
1. 10.1177/0261192923115775610.1177/02611929231157756 ↗
2. 10.1093/hmg/ddv46410.1093/hmg/ddv464 ↗
3. 10.1038/nrm185810.1038/nrm1858 ↗
4. 10.1039/C2TX20051A10.1039/C2TX20051A ↗
5. 10.1089/adt.2011.037110.1089/adt.2011.0371 ↗
6. 10.1038/ncb351610.1038/ncb3516 ↗
7. 10.1038/s41586-020-2724-810.1038/s41586-020-2724-8 ↗
8. 10.1038/s43856-022-00209-110.1038/s43856-022-00209-1 ↗
9. 10.1038/s44222-023-00063-310.1038/s44222-023-00063-3 ↗
10. 10.1038/s41551-018-0246-610.1038/s41551-018-0246-6 ↗
11. 10.1038/ctg.2016.5410.1038/ctg.2016.54 ↗
12. 10.1021/acs.molpharmaceut.6b0116510.1021/acs.molpharmaceut.6b01165 ↗
13. 10.1016/j.ejpb.2014.03.01710.1016/j.ejpb.2014.03.017 ↗
14. 10.1016/j.actbio.2017.10.01710.1016/j.actbio.2017.10.017 ↗
15. 10.3109/09637486.2015.107779210.3109/09637486.2015.1077792 ↗
16. 10.1002/(SICI)1520-6017(200001)89:1<63::AID-JPS7>3.0.CO;2-610.1002/(SICI)1520-6017(200001)89:1<63::AID-JPS7>3.0.CO;2-6 ↗
17. 10.1021/acs.biomac.9b0105310.1021/acs.biomac.9b01053 ↗
18. 10.1039/D3BM01046E10.1039/D3BM01046E ↗
19. 10.1098/rsif.2022.068210.1098/rsif.2022.0682 ↗
20. 10.1038/s41570-022-00407-410.1038/s41570-022-00407-4 ↗
21. 10.1021/acs.jpclett.5b0109610.1021/acs.jpclett.5b01096 ↗
22. 10.1021/acs.biomac.2c0109710.1021/acs.biomac.2c01097 ↗
23. 10.5194/acp-12-2541-201210.5194/acp-12-2541-2012 ↗
24. 10.1038/srep4189010.1038/srep41890 ↗
25. 10.1038/s41598-022-15545-410.1038/s41598-022-15545-4 ↗
26. 10.5194/egusphere-2023-270510.5194/egusphere-2023-2705 ↗
27. 10.1021/jacsau.3c0005610.1021/jacsau.3c00056 ↗
28. 10.1021/acsami.2c1828810.1021/acsami.2c18288 ↗
29. 10.1021/acs.biomac.2c0079110.1021/acs.biomac.2c00791 ↗
30. 10.1038/s41598-022-15545-410.1038/s41598-022-15545-4 ↗
31. 10.1016/j.cryobiol.2020.02.00810.1016/j.cryobiol.2020.02.008 ↗
32. 10.1039/D3CC02252H10.1039/D3CC02252H ↗
33. 10.1021/acs.biomac.0c0059110.1021/acs.biomac.0c00591 ↗
34. 10.1177/221106821456102510.1177/2211068214561025 ↗
35. 10.1007/978-3-030-73317-9_94-110.1007/978-3-030-73317-9_94-1 ↗
36. 10.1002/jps.2007510.1002/jps.20075 ↗
37. 10.1039/C8RA05992F10.1039/C8RA05992F ↗
38. 10.1038/ncomms1562310.1038/ncomms15623 ↗
39. 10.1016/j.xphs.2020.07.00110.1016/j.xphs.2020.07.001 ↗
40. 10.1038/s43586-022-00118-610.1038/s43586-022-00118-6 ↗
41. 10.1021/js950269u10.1021/js950269u ↗
42. 10.1042/BSR2017149710.1042/BSR20171497 ↗
43. 10.1016/0016-5085(90)90334-W10.1016/0016-5085(90)90334-W ↗
44. 10.1016/j.jamcollsurg.2015.12.00610.1016/j.jamcollsurg.2015.12.006 ↗
45. 10.3390/pharmaceutics1509233810.3390/pharmaceutics15092338 ↗
46. 10.1023/a:100813610392710.1023/a:1008136103927 ↗
47. 10.1007/s00216-019-02336-610.1007/s00216-019-02336-6 ↗
48. 10.1016/j.bbrep.2022.10131410.1016/j.bbrep.2022.101314 ↗
49. 10.1038/nrm295710.1038/nrm2957 ↗
50. 10.1016/S0079-6107(02)00037-810.1016/S0079-6107(02)00037-8 ↗